* Vaxart Inc VXRT.OQ VXRT.O is expected to show a fall
in
quarterly revenue when it reports results on November 13 for
the period ending September 30 2024
* The South San Francisco California-based company is
expected to
report a 59.5% decrease in revenue to $850 thousand from $2.1
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Vaxart Inc is for a loss
of 10
cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Vaxart Inc
is
$4.00, above its last closing price of $0.69.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jan. 1 0001 0.01 -0.03 -0.09 Missed -237.5
Dec. 31 0001 -0.14 -0.14 -0.14 Met 0
Dec. 31 2023 -0.16 -0.14 -0.12 Beat 17.2
Sep. 30 2023 -0.18 -0.18 -0.11 Beat 37.7
Jun. -0.18 -0.18 -0.16 Beat 11.1
30 2023
Mar. 31 2023 -0.18 -0.19 -0.19 Met -1.8
Dec. 31 2022 -0.22 -0.23 -0.18 Beat 20.9
Sep. 30 2022 -0.25 -0.24 -0.23 Beat 5.2
This summary was machine generated November 12 at 03:52 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)